Drug intelligence / Profile preview

Medox

Development stage
Unknown
Lead developer
CAPS Holdings
Modality
Small Molecules
Administration
Oral
01

Overview

Medox is a brand of nutritional supplements manufactured by CAPS Holdings, the largest pharmaceutical company in Zimbabwe. The Medox product line includes several formulations designed to address vitamin and mineral deficiencies and support general health. The flagship product, **Medox 12+12**, is a comprehensive multivitamin and multimineral supplement containing 12 essential vitamins (including A, B-complex, C, D, E, and K) and 12 minerals (such as iron, calcium, and zinc). Another prominent product is **Medox C Forte**, which provides a high dose of Vitamin C (500 mg of ascorbic acid) in a chewable tablet format. Historically, the brand has also included specific formulations like Medox BCO (Vitamin B Complex) and Medox Vitamin A tablets. These products are marketed as over-the-counter (OTC) medicines and are widely used in Zimbabwe and the surrounding region for the prevention and treatment of nutritional deficiencies.

Brand names
Medox 12+12Medox C ForteMedox BCOMedox Vitamin A
Other names
Medox Vitamins
02

Targets

GGCX (Vitamin K-dependent gamma-glutamyl carboxylase)VDR (Vitamin D receptor)RAR (Retinoic acid receptor)PHD1 (Prolyl hydroxylase domain-containing protein 1)

Beyond the preview

Go deeper on Medox.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medox.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call